Evidence map›Paper›PMID 29750566›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2018

Advanced age results in a diminished endothelial glycocalyx.

Daniel R Machin, Samuel I Bloom, Robert A Campbell, Tam T T Phuong, Phillip E Gates, Lisa A Lesniewski, Matthew T Rondina, Anthony J Donato

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Biomarkers of endothelial glycocalyx dysfunction in pregnancy: a systematic review of clinical relevance and detection techniques.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Endothelial Exostosin-1 Is Needed for Glycocalyx Integrity and Inflammatory Resolution in Acute Lung Injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Glycocalyx and basal lamina in neurological disorders.Matrix biology : journal of the International Society for Matrix Biology · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. Western diet-induced endothelial glycocalyx remodeling is partially reversed by fasting.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Daniel R MachinGeriatric Research, Education, and Clinical Center, Veterans Affairs Salt Lake City, Salt Lake City, Utah.ORCID 0000-0002-2509-4686
Samuel I BloomDepartment of Nutrition and Integrative Physiology, University of Utah , Salt Lake City, Utah.
Robert A CampbellDepartment of Internal Medicine, University of Utah , Salt Lake City, Utah.
Tam T T PhuongDepartment of Internal Medicine, University of Utah , Salt Lake City, Utah.
Phillip E GatesDepartment of Internal Medicine, University of Utah , Salt Lake City, Utah.
Lisa A LesniewskiGeriatric Research, Education, and Clinical Center, Veterans Affairs Salt Lake City, Salt Lake City, Utah.
Matthew T RondinaGeriatric Research, Education, and Clinical Center, Veterans Affairs Salt Lake City, Salt Lake City, Utah.
Anthony J DonatoGeriatric Research, Education, and Clinical Center, Veterans Affairs Salt Lake City, Salt Lake City, Utah.
University of Utah · US

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
UT StrokeNetU10NS086606 · NINDS · UNIVERSITY OF UTAH · PI MAJERSIK, JENNIFER JUHL · 2013 to 2017
$1.8M
Platelet Immune Responses in Aging and InfluenzaR01AG048022 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2014 to 2018
$1.8M
Mechanisms of augmented atherosclerotic progression with agingR01AG048366 · NIA · UNIVERSITY OF UTAH · PI LESNIEWSKI, LISA A · 2016 to 2020
$1.7M
Telomere uncapping and arterial dysfunction: Novel mechanism and implications for agingR01AG050238 · NIA · UNIVERSITY OF UTAH · PI DONATO, ANTHONY JOHN · 2016 to 2020
$1.6M
The role of hyaluronan in age-related vascular and skeletal muscle dysfunctionR00AT010017 · NCCIH · FLORIDA STATE UNIVERSITY · PI MACHIN, DANIEL ROBERT · 2020 to 2022
$747k
Amelioration of aged endothelial dysfunction by NAMPT and caloric restrictionK02AG045339 · NIA · UNIVERSITY OF UTAH · PI DONATO, ANTHONY JOHN · 2014 to 2018
$558k
The role of hyaluronan in age-related vascular and skeletal muscle dysfunctionK99AT010017 · NCCIH · UNIVERSITY OF UTAH · PI MACHIN, DANIEL ROBERT · 2018 to 2019
$261k
Metabolic implications of adipose arterial function: Role of Robo4 and AMPKI01BX002151 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI LESNIEWSKI, LISA A · 2015 to 2018
–
BLRD VA I01 BX002151NCATS NIH HHS UL1 TR002538NCCIH NIH HHS K99 AT010017NCCIH NIH HHS R00 AT010017NIA NIH HHS K02 AG045339NIA NIH HHS R01 AG048022NIA NIH HHS R01 AG048366NIA NIH HHS R01 AG050238NINDS NIH HHS U10 NS086606
6 · The paper itself

Abstract

Age-related microvascular dysfunction is well characterized in rodents and humans, but little is known about the properties of the microvascular endothelial glycocalyx in advanced age. We examined the glycocalyx in microvessels of young and old male C57BL6 mice (young: 6.1 ± 0.1 mo vs. old: 24.6 ± 0.2 mo) using intravital microscopy and transmission electron microscopy and in human participants (young: 29 ± 1 yr vs. old: 60 ± 2 yr) using intravital microscopy. Glycocalyx thickness in mesenteric and skeletal muscle microvessels was 51-54% lower in old compared with young mice. We also observed 33% lower glycocalyx thickness in the sublingual microcirculation of humans in advanced age. The perfused boundary region, a marker of glycocalyx barrier function, was also obtained using an automated capture and analysis system. In advanced age, we observed a 10-22% greater perfused boundary region in mice and humans, indicating a more penetrable glycocalyx. Finally, using this automated analysis system, we examined perfused microvascular density and red blood cell (RBC) fraction. Perfused microvascular density is a marker of microvascular function that reflects the length of perfused microvessel segments in a given area; RBC fraction represents the heterogeneity in RBC presence between microvessel segments. Compared with young, the perfused microvascular density was 16-21% lower and RBC fraction was 5-14% lower in older mice and in older humans. These data provide novel evidence that, across mammalian species, a diminished glycocalyx is present in advanced age and is accompanied by markers of impaired microvascular perfusion. Age-related glycocalyx deterioration may be an important contributor to microvascular dysfunction in older adults and subsequent pathophysiology. NEW & NOTEWORTHY Advanced age is characterized by microvascular dysfunction that contributes to age-related cardiovascular diseases, but little is known about endothelial glycocalyx properties in advanced age. This study reveals, for the first time, lower glycocalyx thickness and barrier function that is accompanied by impaired microvascular perfusion in both mice and humans in advanced age.

Indexed as

AdultAgingAnimalsEndothelium, VascularFemaleGlycocalyxHumansMaleMiceMice, Inbred C57BLMiddle Agedagingelectron microscopyintravital microscopymicrocirculationmicrovascular perfusion

Identifiers

PMID29750566
PMCPMC6172638
OpenAlexW2802297028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.